Selkoe to discuss #amyloid and #Alzheimer’s in wake of another disappointing drug study

A recent story in The Atlantic asks "Is the Leading Theory About Alzheimer's Wrong?" For years, scientist have been arguing about whether amyloid protein in the brain is a cause,or just a symptom of condition.  Pharma has been confident -- or desperate -- enough in the science to bet on amyloid clearing drugs, but they … Continue reading Selkoe to discuss #amyloid and #Alzheimer’s in wake of another disappointing drug study

From today’s Boston Globe: Partners and Trump, health costs and another expensive drug

STAT News reports that Partners Healthcare CEO Dr. David Torchiana was among the health care executive who met with President-elect Donald Trump Wenesday.  Torchiana has been among those arguing that repeal of the law could disrupt millions of families who have relied upon it for insurance coverage. “De-insuring 20 million people, many of whom were probably Trump … Continue reading From today’s Boston Globe: Partners and Trump, health costs and another expensive drug

From Health Leaders: Shame, fear and medical errors

From a recent talk at Harvard by Danielle Ofri, MD, author of What Doctors Feel. Ofri's talk centered on one emotion, shame, which she said overwhelms many doctors and is a major reason many medical errors go unaddressed. When errors are not acknowledged, even those without bad outcomes, no one learns from them, she said. … Continue reading From Health Leaders: Shame, fear and medical errors

Should Boston Children’s Hospital expansion go forward? Opponents cite higher costs, smaller garden.

Planned to write a post linking to the wave of endorsements and opposition to the proposed expansion at Boston's Children's Hospital, but the Globe columnist Joan Vennochi did it for me. Her opinion piece  links to the various supporters -Gov. Charlie  Globe's staff editorial endorsing the plan.  BHN is in the reporting, not the endorsing, business. So, FYI. … Continue reading Should Boston Children’s Hospital expansion go forward? Opponents cite higher costs, smaller garden.

Can #Massachusetts tame #health #spending with transparency and oversight?

Stuart Altman, the Brandeis University healthcare economist who has advised presidents from Nixon to Obama, talked to Health Leaders last week. He is now  the head of the Massachusetts Health Policy Commission, which tracks total health spending statewide.   HLM: How is Massachusetts trying to address high costs? Altman: First of all, it is the … Continue reading Can #Massachusetts tame #health #spending with transparency and oversight?

The New Yorker:#Boston researchers are hunting for a #Zika vaccine — trco201

The August 22 edition of The New Yorker includes a story by Siddhartha Mukhergee on Dan Barouch, director, Center for Virology and Vaccine Research at BIDMC. He’s on the hunt for a Zika vaccine and his work on HIV is informing the effort. From the article, which is not behind the NYer pay wall:  

Are two big #hospital groups better than one? #consolidation

At Wednesday's meeting, the  Massachusetts Health Policy Commission heard a staff report on the proposed merger of Beth Israel Deaconess Medical Center  In summary, we find that these transactions are anticipated to increase market concentration, solidify BIDCO’s position as the second largest hospital network in the state, and could strengthen BIDCO’s ability to leverage higher … Continue reading Are two big #hospital groups better than one? #consolidation